M

    MiMedx Group Inc (MDXG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.54
    +0.04 (+0.89%)

    Market Cap: $655.92M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(25/38)
    Avg Surprise
    +3.45%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.01
    Range$-0.02 - $0.05
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$-0.00-137.3%
    60d ago$-0.00-137.3%
    30d ago$-0.00-149.3%
    7d ago$-0.00-149.3%
    Current$0.01
    Revenue Consensus
    $70M
    Range$66M - $72M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.04 - $0.09
    3 analysts
    Revenue Consensus
    $70M
    Range$61M - $75M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$0.01---
    Jun 26
    		$-0.05$-0.03-66.67%Miss-150.0%
    Mar 26
    		$-0.05$-0.04-25.00%Miss-200.0%
    Dec 25
    		$0.14$0.09+50.70%Beat+100.0%
    Sep 25
    		$0.15$0.08+87.50%Beat+114.3%
    Jun 25
    		$0.10$0.06+66.67%Beat+25.0%
    Mar 25
    		$0.05$0.06-16.67%Miss-28.6%
    Dec 24
    		$0.07$0.07-6.67%Miss-78.1%
    Sep 24
    		$0.07$0.05+40.00%Beat+40.0%
    Jun 24
    		$0.08$0.08+0.00%Beat+1839.1%
    Mar 24
    		$0.07$0.04+75.00%Beat+333.3%
    Dec 23
    		$0.32$0.07+357.14%Beat+1700.0%
    Sep 23
    		$0.05$0.05+0.00%Beat+183.3%
    Jun 23
    		$-0.00N/A+84.67%Beat+94.2%
    Mar 23
    		$-0.03N/A+57.14%Beat+66.7%
    Dec 22
    		$-0.02$-0.04+50.00%Beat-300.0%
    Sep 22
    		$-0.06$-0.12+50.00%Beat-500.0%
    Jun 22
    		$-0.08$-0.08+0.00%Beat-60.0%
    Mar 22
    		$-0.09$-0.10+10.00%Beat+0.0%
    Dec 21
    		$0.01N/A+133.33%Beat+105.9%
    Sep 21
    		$-0.01N/A+85.71%Beat-103.7%
    Jun 21
    		$-0.05$-0.08+37.50%Beat-171.4%
    Mar 21
    		$-0.09N/A+52.63%Beat-12.5%
    Dec 20
    		$-0.17$-0.05-240.00%Miss-144.7%
    Sep 20
    		$0.27N/AN/ABeat+145.5%
    Jun 20
    		$0.07$0.12-41.67%Miss+143.8%
    Mar 20
    		$-0.08$0.00N/AMiss+33.3%
    Dec 19
    		$0.38$0.09+322.22%Beat+404.7%
    Sep 19
    		$0.11$0.15-26.67%Miss+133.2%
    Jun 19
    		$-0.16$0.14-214.29%Miss-1087.7%
    Mar 19
    		$-0.12$0.13-192.31%Miss-233.3%
    Dec 18
    		$-0.12$0.14-189.07%Miss-224.7%
    Sep 18
    		$-0.33$0.13-355.23%Miss-514.8%
    Jun 18
    		$0.02N/A-85.27%Miss-76.9%
    Mar 18
    		$0.09$0.09+0.00%Beat+28.6%
    Dec 17
    		$0.10$0.07+42.86%Beat+42.9%
    Sep 17
    		$0.08$0.08+0.00%Beat+33.3%
    Jun 17
    		$0.07$0.07+0.00%Beat-
    Mar 17
    		$0.07$0.07+0.00%Beat-
    Dec 16
    		$0.07$0.08-12.50%Miss-
    Sep 16
    		$0.06$0.06+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio23.89EV/EBITDA26.47x
    Price/FCF15.08xFCF Yield6.63%
    Profitability
    Profit Margin1.76%Operating Margin-28.70%
    ROE2.88%ROIC2.28%
    Financial Health
    Debt/Equity0.08xInterest CoverageN/A
    Current Ratio5.33xQuick Ratio4.79x
    Trading Statistics
    Beta1.41Avg Volume1.15M
    52-Week High$7.9752-Week Low$3.03

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.40
    SMA 20$4.32
    SMA 50$4.20
    SMA 200$4.77
    EMA 10$4.41
    EMA 20$4.35
    EMA 50$4.21
    EMA 200$4.73

    MACD

    Line: 0.08Signal: 0.07Hist: 0.02

    ADX

    ADX: 17.0+DI: 27.6-DI: 16.0

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down12.0
    PSAR$4.13

    Bollinger Bands

    Upper Band$4.55
    Lower Band$4.10
    %B Position1025%(Upper)
    Band Width0.99

    RSI (14-Day)

    Neutral
    61.9

    Momentum Oscillators

    Stoch %K62.0
    Stoch %D65.5
    Williams %R-34.4
    ROC (10d)8.4%
    Momentum0.35
    CCI (20d)141.5
    MFI (14d)43.4

    Volatility Measures

    ATR (14d)$0.18(3.9%)
    StdDev (20d)0.11
    Hist Vol32.2%(Moderate)

    Volume Flow

    VWAP$4.50
    OBV-7.1M
    AD Line-7.8M
    CMF (20d)-0.029

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.0x
    VWMA (20d)$4.32

    Pivot Points

    R3$4.75
    R2$4.69
    R1$4.60
    Pivot Point$4.54
    S1$4.44
    S2$4.38
    S3$4.29

    Advanced Oscillators

    TSI14.54
    Ultimate Osc48.7
    KST44.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$64.36M$58.99M$118.09M$113.72M$98.61M$88.20M$92.91M$84.06M$87.21M$84.71M$86.83M$81.71M
    Cost of Revenue$19.98M$17.37M$19.05M$18.72M$18.68M$16.56M$16.91M$15.32M$14.86M$12.99M$13.84M$14.79M
    Gross Profit$44.38M$41.62M$99.04M$95.01M$79.92M$71.65M$76.00M$68.73M$72.35M$71.72M$72.99M$66.92M
    Operating Expenses$62.85M$57.67M$77.96M$72.82M$67.55M$63.40M$64.94M$57.57M$48.90M$58.52M$57.50M$55.80M
    R&D$2.78M$4.14M$4.76M$3.70M$3.30M$3.33M$3.57M$2.92M$3.01M$2.84M$2.43M$3.08M
    SG&A$59.78M$53.23M$73.07M$69.00M$64.15M$59.97M$61.04M$53.52M$55.40M$55.13M$54.35M$52.57M
    Operating Income$-18,466,000$-16,049,000$21.08M$22.19M$12.37M$8.25M$11.05M$11.16M$23.45M$13.20M$15.49M$11.12M
    Interest Income$788,000$886,000$904,000$785,000$738,000$506,000$403,000$278,000$3,000$-1,690,000$0$-1,680,000
    Interest Expense$0$0$0$0$0$0$0$0$234,000$1.79M$1.58M$1.69M
    Income Before Tax$-17,780,000$-15,331,000$21.79M$22.85M$13.01M$8.61M$11.25M$11.42M$23.22M$11.41M$13.91M$9.43M
    Income Tax Expense$-2,940,000$-4,471,000$6.61M$6.10M$3.39M$1.59M$3.81M$3.54M$5.59M$2.35M$-37,374,000$591,000
    Net Income$-14,840,000$-10,860,000$15.19M$16.75M$9.62M$7.02M$7.44M$8.10M$17.63M$9.26M$53.48M$8.53M
    EBITDA$-17,037,000$-14,600,000$24.11M$27.35M$15.44M$11.31M$13.84M$12.30M$24.36M$13.91M$16.88M$12.33M
    EBIT$-18,568,000$-16,217,000$20.89M$22.06M$12.27M$8.11M$10.85M$11.14M$23.21M$13.10M$15.51M$11.11M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MDXG

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close

    Sanara MedTech Inc. (SMTI) has entered into a definitive agreement to be acquired by MiMedx Group, Inc., aiming to create a leading regenerative medicine company. The transaction, which is subject to regulatory and stockholder approvals, is expected to close by the end of the year. Both companies will operate independently until closing, with existing distributor agreements remaining unchanged.

    Stock Titan•8/21/26•
    Neutral

    MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal

    MiMedx Group has clarified the termination fees for its merger with Sanara MedTech Inc., stating Sanara would owe $9.66 million in specific cases and MiMedx $22.54 million if it fails to close. The deal offers Sanara shareholders $33.00 cash plus 0.4735 shares of MiMedx common stock per share, and MiMedx has secured a $300 million loan to finance the acquisition. The transaction is subject to Sanara stockholder and antitrust approvals, with a voting agreement covering 38.9% of Sanara's voting power already in place.

    Stock Titan•8/12/26•
    Somewhat-Bullish

    Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees

    Sanara MedTech Inc. has confirmed the terms of its merger with MiMedx Group, Inc., where each Sanara share will convert into $33.00 in cash and 0.4735 shares of MiMedx common stock, valued at $2.00 per share. This amendment also corrects previously misstated termination fees, with Sanara owing $9,660,336.00 to MiMedx in specific scenarios and MiMedx owing Sanara $22,540,785.00 if it fails to close the deal. The merger is supported by a voting agreement covering approximately 38.9% of Sanara's voting power and is subject to regulatory and stockholder approvals with an outside date of July 29, 2027.

    Stock Titan•8/11/26•
    Bullish

    MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG

    This article provides a revenue breakdown for MiMedx Group, Inc (NASDAQ: MDXG). Last year, the company generated $418.63 million USD in total revenue, with its Wound segment being the top performer, contributing $276.33 million USD. The United States was the greatest regional contributor to revenue, accounting for the entire $418.63 million USD.

    TradingView•8/9/26•
    Neutral

    MiMedx Group Inc (MDXG) Stock News Today

    This article from TradingKey provides current stock information for MiMedx Group Inc (MDXG), including its stock price, market cap, and P/E ratio. It notes that more news regarding MDXG's earnings, analyst ratings, and key developments will be available soon. The page serves as a hub for financial data and future news updates for the company.

    TradingKey•8/8/26•
    Neutral

    Frequently Asked Questions About MDXG

    Does MDXG pay dividends?
    MiMedx Group Inc (MDXG) does not currently pay a regular dividend.
    What is MDXG's P/E ratio?
    MiMedx Group Inc has a price-to-earnings (P/E) ratio of 23.89.
    What is MDXG's market cap?
    MiMedx Group Inc (MDXG) has a market capitalization of $655.92M with a current stock price of $4.54.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In